insights_auto
Why is MBIO down 7,37%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
US$0,42
arrow_downward
-7,37%(-0,033) 1D
US$0,40
arrow_downward
-4,03% (-0,017)bedtimeAfter hours
Closed: 8 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
US$0,45
High
US$0,45
Low
US$0,41
Mkt. cap
3,16 ລ້ານ
Avg. vol.
26,25 ພັນ
Volume
0,00
52-wk high
US$1,84
52-wk low
US$0,41
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
Open
US$0,45
High
US$0,45
Low
US$0,41
Mkt. cap
3,16 ລ້ານ
Avg. vol.
26,25 ພັນ
Volume
0,00
52-wk high
US$1,84
52-wk low
US$0,41
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
News stories
From web sources and news partners
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitemustangbio.com